Why is fair value unavailable for Sofgen Pharma SA (OTC-PROC.F) stock?

A reliable fair value estimate is not currently available for Sofgen Pharma SA (OTC-PROC.F). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

How is the financial health of Sofgen Pharma SA?

The current financial health read for Sofgen Pharma SA (OTC-PROC.F) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Does Sofgen Pharma SA (OTC-PROC.F) pay dividends?

The latest available data indicates no current dividend yield for Sofgen Pharma SA (OTC-PROC.F).

What is the market capitalization of Sofgen Pharma SA?

The current market capitalization listed for Sofgen Pharma SA is 43.069 M.

What is the ticker symbol for Sofgen Pharma SA?

The ticker symbol for Sofgen Pharma SA is OTC-PROC.F, and the stock is listed on OTC Markets.

Where is Sofgen Pharma SA (OTC-PROC.F) listed?

Sofgen Pharma SA (OTC-PROC.F) is listed on OTC Markets.

Sofgen Pharma SA (PROCF) Fair Value & Stock Analysis

Sofgen Pharma SA (PROCF)

Sofgen Pharma S.A. is a Luxembourg-based pharmaceutical company listed on OTC Markets as common stock. Through its subsidiaries, the company develops, manufactures, and sells pharmaceutical products and healthcare solutions across South America, Central America, North America, and Europe. Its operations are organized into five segments: NextGel, Procaps Colombia, Central America North, Central America South and North Andes, and Diabetrics.

The company’s portfolio includes softgel technologies and related products sold under brands such as Softigel, Sofgen, Softcaps, and Funtrition. It also markets branded prescription medicines, hospital-use high-complexity drugs, and over-the-counter consumer healthcare products. In addition, Sofgen Pharma develops diabetes-related products and medical delivery items, including blood glucose meters, insulin delivery systems, syringes, and sterile pharmaceutical packaging and dosage forms. The company was formerly known as Procaps Group S.A. and was founded in 1977.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Market Cap
OTC-PROC.F	Not available	Not available	Not available	Fair	0.0%	43.069 M